Abstract

Here, we illustrate what happens inside the catalytic cleft of an enzyme when substrate or ligand binds on single-millisecond timescales. The initial phase of the enzymatic cycle is observed with near-atomic resolution using the most advanced X-ray source currently available: the European XFEL (EuXFEL). The high repetition rate of the EuXFEL combined with our mix-and-inject technology enables the initial phase of ceftriaxone binding to the Mycobacterium tuberculosis β-lactamase to be followed using time-resolved crystallography in real time. It is shown how a diffusion coefficient in enzyme crystals can be derived directly from the X-ray data, enabling the determination of ligand and enzyme-ligand concentrations at any position in the crystal volume as a function of time. In addition, the structure of the irreversible inhibitor sulbactam bound to the enzyme at a 66 ms time delay after mixing is described. This demonstrates that the EuXFEL can be used as an important tool for biomedically relevant research.

Highlights

  • Combatting the rise of infectious diseases requires a collaborative and interdisciplinary approach

  • The initial phase of the enzymatic cycle is observed with near-atomic resolution using the most advanced X-ray source currently available: the European XFEL (EuXFEL)

  • The high repetition rate of the EuXFEL combined with our mix-andinject technology enables the initial phase of ceftriaxone binding to the Mycobacterium tuberculosis -lactamase to be followed using time-resolved crystallography in real time

Read more

Summary

Introduction

Combatting the rise of infectious diseases requires a collaborative and interdisciplinary approach. Structural biologists can contribute by investigating the reaction mechanisms of biomedically significant enzymes as a structural basis to develop cures for diseases. Bacterial infections with strains that are resistant to currently available antibiotics are on the rise (Cassini et al, 2019). 8, 878–895 research papers currently available drugs are central to antibiotic resistance (Fair & Tor, 2014), and unraveling the catalytic mechanism of these enzymes will be beneficial for the development of novel antibiotics (Imming et al, 2006). Infectious diseases that could be treated with antibiotics in the past may become untreatable. This warrants the investigation of the structure and function of these enzymes

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call